{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T16:47:39Z","timestamp":1758386859266,"version":"3.44.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100010793","name":"Pfizer Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010793","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s40120-025-00812-z","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T02:14:13Z","timestamp":1755569653000},"page":"2137-2159","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Differences in Patient-Physician Satisfaction for Migraine Treatment Medications in Patients with and without Medication-Overuse Headache: A Cross-Sectional Real-World Survey"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6976-1081","authenticated-orcid":false,"given":"Ryotaro","family":"Ishii","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2467-3149","authenticated-orcid":false,"given":"Takahiro","family":"Kitano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3462-1652","authenticated-orcid":false,"given":"Masahiro","family":"Iijima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6796-2268","authenticated-orcid":false,"given":"Mitsuhiro","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2341-3601","authenticated-orcid":false,"given":"Reiko","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4171-5390","authenticated-orcid":false,"given":"James","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5604-1360","authenticated-orcid":false,"given":"Sophie","family":"Barlow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1689-6614","authenticated-orcid":false,"given":"Emily","family":"Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8342-2125","authenticated-orcid":false,"given":"William","family":"Whitton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7925-8175","authenticated-orcid":false,"given":"Lucy","family":"Hargreaves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3964-4009","authenticated-orcid":false,"given":"Kanae","family":"Togo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,19]]},"reference":[{"issue":"1","key":"812_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417738202","volume":"38","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2018","unstructured":"Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition. Cephalalgia. 2018;38(1):1\u2013211.","journal-title":"Cephalalgia"},{"issue":"1","key":"812_CR2","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s11916-011-0233-z","volume":"16","author":"Z Katsarava","year":"2012","unstructured":"Katsarava Z, Buse DC, Manack AN, Lipton RB. Defining the differences between episodic migraine and chronic migraine. Curr Pain Headache Rep. 2012;16(1):86\u201392.","journal-title":"Curr Pain Headache Rep"},{"issue":"11","key":"812_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-038987","volume":"10","author":"H Igarashi","year":"2020","unstructured":"Igarashi H, Ueda K, Jung S, Cai Z, Chen Y, Nakamura T. Social burden of people with the migraine diagnosis in Japan: evidence from a population-based cross-sectional survey. BMJ Open. 2020;10(11): e038987.","journal-title":"BMJ Open"},{"issue":"1","key":"812_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-020-01208-0","volume":"21","author":"TJ Steiner","year":"2020","unstructured":"Steiner TJ, Stovner LJ, Jensen R, Uluduz D, Katsarava Z, on behalf of Lifting The Burden: the Global Campaign against H. Migraine remains second among the world\u2019s causes of disability, and first among young women: findings from GBD2019. J Headache Pain. 2020;21(1): 137.","journal-title":"J Headache Pain"},{"issue":"10440","key":"812_CR5","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/S0140-6736(24)00476-8","volume":"403","author":"GBD 2021 Demographics Collaborators","year":"2024","unstructured":"GBD 2021 Demographics Collaborators. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950\u20132021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):1989\u20132056.","journal-title":"Lancet"},{"issue":"1","key":"812_CR6","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s10194-020-01180-9","volume":"21","author":"S Kikui","year":"2020","unstructured":"Kikui S, Chen Y, Todaka H, Asao K, Adachi K, Takeshima T. Burden of migraine among Japanese patients: a cross-sectional national health and wellness survey. J Headache Pain. 2020;21(1):110.","journal-title":"J Headache Pain"},{"issue":"1","key":"812_CR7","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s40120-023-00569-3","volume":"13","author":"E Awaki","year":"2024","unstructured":"Awaki E, Takeshima T, Matsumori Y, Hirata K, Miyazaki N, Takemura R, et al. Impact of migraine on daily life: results of the observational survey of the epidemiology, treatment, and care of migraine (OVERCOME [Japan]) study. Neurol Ther. 2024;13(1):165\u201382.","journal-title":"Neurol Ther"},{"key":"812_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1440733","author":"R Ishii","year":"2024","unstructured":"Ishii R, Sakai F, Sano H, Nakai M, Koga N, Matsukawa M. Quality of life and work productivity and activity impairment among online survey respondents with migraine across a range of headache frequency. Front Neurol. 2024. https:\/\/doi.org\/10.3389\/fneur.2024.1440733.","journal-title":"Front Neurol"},{"key":"812_CR9","unstructured":"Headache Clinical Practice Guideline Development Committee. Clinical practice guideline for headache disorders 2021. Tokyo: Japanese Society of Neurology, Japanese Headache Society, Japanese Society of Neurological Therapeutics, Ed., Igaku-Shoin; 2021."},{"key":"812_CR10","doi-asserted-by":"publisher","unstructured":"Takeshima T, Kikui S, Danno D. Migraine management in japan: current approaches and science narrative including an evidence-based review. Intern Med. 2024;4846\u201324. https:\/\/doi.org\/10.2169\/internalmedicine.4846-24.","DOI":"10.2169\/internalmedicine.4846-24"},{"issue":"4","key":"812_CR11","first-page":"243","volume":"97","author":"L Mayans","year":"2018","unstructured":"Mayans L, Walling A. Acute migraine headache: treatment strategies. Am Fam Physician. 2018;97(4):243\u201351.","journal-title":"Am Fam Physician"},{"issue":"1","key":"812_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-024-01737-y","volume":"25","author":"T Takizawa","year":"2024","unstructured":"Takizawa T, Ihara K, Watanabe N, Takemura R, Takahashi N, Miyazaki N, et al. CGRP-monoclonal antibodies in Japan: insights from an online survey of physician members of the Japanese Headache Society. J Headache Pain. 2024;25(1): 39.","journal-title":"J Headache Pain"},{"issue":"Suppl 2","key":"812_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/head.13582","volume":"59","author":"D Moreno-Ajona","year":"2019","unstructured":"Moreno-Ajona D, Chan C, Villar-Mart\u00ednez MD, Goadsby PJ. Targeting CGRP and 5-HT(1F) receptors for the acute therapy of migraine: a literature review. Headache. 2019;59(Suppl 2):3\u201319.","journal-title":"Headache"},{"issue":"7","key":"812_CR14","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1212\/WNL.0000000000001256","volume":"84","author":"RB Lipton","year":"2015","unstructured":"Lipton RB, Fanning KM, Serrano D, Reed ML, Cady R, Buse DC. Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraine. Neurology. 2015;84(7):688\u201395.","journal-title":"Neurology"},{"key":"812_CR15","doi-asserted-by":"publisher","unstructured":"Kebede YT, Mohammed BD, Tamene BA, Abebe AT, Dhugasa RW. Medication overuse headache: a review of current evidence and management strategies. Front Pain Res. 2023;4. https:\/\/doi.org\/10.3389\/fpain.2023.1194134.","DOI":"10.3389\/fpain.2023.1194134"},{"issue":"11","key":"812_CR16","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1111\/j.1468-2982.2008.01736.x","volume":"28","author":"R Kanki","year":"2008","unstructured":"Kanki R, Nagaseki Y, Sakai F. Medication-overuse headache in Japan. Cephalalgia. 2008;28(11):1227\u20138.","journal-title":"Cephalalgia"},{"issue":"6","key":"812_CR17","doi-asserted-by":"publisher","first-page":"3811","DOI":"10.1007\/s10072-021-05831-w","volume":"43","author":"M Katsuki","year":"2022","unstructured":"Katsuki M, Yamagishi C, Matsumori Y, Koh A, Kawamura S, Kashiwagi K, et al. Questionnaire-based survey on the prevalence of medication-overuse headache in Japanese one city\u2014Itoigawa study. Neurol Sci. 2022;43(6):3811\u201322.","journal-title":"Neurol Sci"},{"issue":"7","key":"812_CR18","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1111\/ene.14268","volume":"27","author":"HC Diener","year":"2020","unstructured":"Diener HC, Antonaci F, Braschinsky M, Evers S, Jensen R, Lainez M, et al. European academy of neurology guideline on the management of medication-overuse headache. Eur J Neurol. 2020;27(7):1102\u201316.","journal-title":"Eur J Neurol"},{"issue":"13","key":"812_CR19","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.3390\/jcm13133696","volume":"13","author":"G G\u00f6\u00e7mez Y\u0131lmaz","year":"2024","unstructured":"G\u00f6\u00e7mez Y\u0131lmaz G, Ghouri R, \u00d6zdemir AA, \u00d6zge A. Complicated form of medication overuse headache is severe version of chronic migraine. J Clin Med. 2024;13(13):3696.","journal-title":"J Clin Med"},{"issue":"6","key":"812_CR20","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s10194-011-0388-3","volume":"12","author":"A Negro","year":"2011","unstructured":"Negro A, Martelletti P. Chronic migraine plus medication overuse headache: two entities or not? J Headache Pain. 2011;12(6):593\u2013601.","journal-title":"J Headache Pain"},{"issue":"1","key":"812_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-024-01755-w","volume":"25","author":"H Gosalia","year":"2024","unstructured":"Gosalia H, Moreno-Ajona D, Goadsby PJ. Medication-overuse headache: a narrative review. J Headache Pain. 2024;25(1): 89.","journal-title":"J Headache Pain"},{"issue":"1","key":"812_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-025-02046-8","volume":"26","author":"R Ishii","year":"2025","unstructured":"Ishii R, Takizawa T, Suzuki S, Danno D, Miura M, Tanizawa Y, et al. Real-world use of over-the-counter medications by patients with migraine in Japan: results from the OVERCOME (Japan) 2nd study. J Headache Pain. 2025;26(1): 107.","journal-title":"J Headache Pain"},{"issue":"11","key":"812_CR23","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1185\/03007990802457040","volume":"24","author":"P Anderson","year":"2008","unstructured":"Anderson P, Benford M, Harris N, Karavali M, Piercy J. Real-world physician and patient behaviour across countries: disease-specific programmes\u2014a means to understand. Curr Med Res Opin. 2008;24(11):3063\u201372.","journal-title":"Curr Med Res Opin"},{"issue":"12","key":"812_CR24","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1080\/03007995.2023.2279679","volume":"39","author":"P Anderson","year":"2023","unstructured":"Anderson P, Higgins V, Courcy Jd, Doslikova K, Davis VA, Karavali M, et al. Real-world evidence generation from patients, their caregivers and physicians supporting clinical, regulatory and guideline decisions: an update on disease specific programmes. Curr Med Res Opin. 2023;39(12):1707\u201315.","journal-title":"Curr Med Res Opin"},{"issue":"8","key":"812_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010352","volume":"6","author":"SM Babineaux","year":"2016","unstructured":"Babineaux SM, Curtis B, Holbrook T, Milligan G, Piercy J. Evidence for validity of a national physician and patient-reported, cross-sectional survey in China and UK: the disease specific programme. BMJ Open. 2016;6(8): e010352.","journal-title":"BMJ Open"},{"key":"812_CR26","doi-asserted-by":"publisher","first-page":"371","DOI":"10.2147\/DMSO.S120101","volume":"9","author":"V Higgins","year":"2016","unstructured":"Higgins V, Piercy J, Roughley A, Milligan G, Leith A, Siddall J, et al. Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015. Diabetes Metab Syndr Obes Targets Ther. 2016;9:371\u201380.","journal-title":"Diabetes Metab Syndr Obes Targets Ther"},{"issue":"7","key":"812_CR27","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/j.1468-2982.2008.01786.x","volume":"29","author":"RB Lipton","year":"2009","unstructured":"Lipton RB, Kolodner K, Bigal ME, Valade D, L\u00e1inez MJ, Pascual J, et al. Validity and reliability of the Migraine-Treatment Optimization Questionnaire. Cephalalgia. 2009;29(7):751\u20139.","journal-title":"Cephalalgia"},{"issue":"6 Suppl 1","key":"812_CR28","first-page":"S20","volume":"56","author":"WF Stewart","year":"2001","unstructured":"Stewart WF, Lipton RB, Dowson AJ, Sawyer J. Development and testing of the Migraine Disability Assessment (MIDAS) questionnaire to assess headache-related disability. Neurology. 2001;56(6 Suppl 1):S20\u20138.","journal-title":"Neurology"},{"issue":"1","key":"812_CR29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0304-3959(00)00305-5","volume":"88","author":"WF Stewart","year":"2000","unstructured":"Stewart WF, Lipton RB, Kolodner KB, Sawyer J, Lee C, Liberman JN. Validity of the migraine disability assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers. Pain. 2000;88(1):41\u201352.","journal-title":"Pain"},{"issue":"5","key":"812_CR30","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1212\/WNL.53.5.988","volume":"53","author":"WF Stewart","year":"1999","unstructured":"Stewart WF, Lipton RB, Whyte J, Dowson A, Kolodner K, Liberman JN, et al. An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score. Neurology. 1999;53(5):988\u201394.","journal-title":"Neurology"},{"key":"812_CR31","unstructured":"European Pharmaceutical Market Research Association (EphMRA). Code of Conduct 2024. https:\/\/www.ephmra.org\/code-conduct-aer. Accessed 7 Aug 2025."},{"issue":"1","key":"812_CR32","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159\u201374.","journal-title":"Biometrics"},{"key":"812_CR33","unstructured":"StataCorp. Stata Statistical Software: Release 18. College Station: StataCorp LLC; 2023."},{"issue":"9","key":"812_CR34","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1111\/j.1468-1331.2011.03497.x","volume":"18","author":"S Evers","year":"2011","unstructured":"Evers S, Jensen R. Treatment of medication overuse headache\u2014guideline of the EFNS headache panel. Eur J Neurol. 2011;18(9):1115\u201321.","journal-title":"Eur J Neurol"},{"issue":"12","key":"812_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0315610","volume":"19","author":"T Takizawa","year":"2024","unstructured":"Takizawa T, Kitano T, Togo K, Yoshikawa R, Iijima M. Clinical practice for migraine treatment and characteristics of medical facilities and physicians treating migraine: insights from a retrospective cohort study using a Japanese claims database. PLoS ONE. 2024;19(12): e0315610.","journal-title":"PLoS ONE"},{"issue":"22","key":"812_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e40190","volume":"10","author":"T Tanei","year":"2024","unstructured":"Tanei T, Fuse Y, Maesawa S, Nishimura Y, Ishizaki T, Nagashima Y, et al. Real-world clinical results of CGRP monoclonal antibody treatment for medication overuse headache of migraine without abrupt drug discontinuation and no hospitalization. Heliyon. 2024;10(22): e40190.","journal-title":"Heliyon"},{"issue":"1","key":"812_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-66906-0","volume":"14","author":"S-Y Oh","year":"2024","unstructured":"Oh S-Y, Kang J-J, Park H-K, Cho S-J, Hong Y, Kang M-K, et al. Three-month treatment outcome of medication-overuse headache according to classes of overused medications, use of acute medications, and preventive treatments. Sci Rep. 2024;14(1): 16013.","journal-title":"Sci Rep"},{"issue":"2","key":"812_CR38","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209584","volume":"103","author":"PJ Goadsby","year":"2024","unstructured":"Goadsby PJ, Friedman DI, Holle-Lee D, Demarquay G, Ashina S, Sakai F, et al. Efficacy of atogepant in chronic migraine with and without acute medication overuse in the randomized, double-blind, phase 3 PROGRESS trial. Neurology. 2024;103(2): e209584.","journal-title":"Neurology"},{"issue":"11","key":"812_CR39","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1001\/jamaneurol.2024.3043","volume":"81","author":"SJ Tepper","year":"2024","unstructured":"Tepper SJ, Dodick DW, Lanteri-Minet M, Dolezil D, Gil-Gouveia R, Lucas C, et al. Efficacy and safety of erenumab for nonopioid medication overuse headache in chronic migraine: a phase 4, randomized, placebo-controlled trial. JAMA Neurol. 2024;81(11):1140\u20139.","journal-title":"JAMA Neurol"},{"issue":"1","key":"812_CR40","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s40120-021-00305-9","volume":"11","author":"Y Matsumori","year":"2022","unstructured":"Matsumori Y, Ueda K, Komori M, Zagar AJ, Kim Y, Jaffe DH, et al. Burden of migraine in Japan: results of the ObserVational Survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) study. Neurol Ther. 2022;11(1):205\u201322.","journal-title":"Neurol Ther"},{"issue":"1","key":"812_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-022-01439-3","volume":"23","author":"F Sakai","year":"2022","unstructured":"Sakai F, Hirata K, Igarashi H, Takeshima T, Nakayama T, Sano H, et al. A study to investigate the prevalence of headache disorders and migraine among people registered in a health insurance association in Japan. J Headache Pain. 2022;23(1): 70.","journal-title":"J Headache Pain"},{"issue":"11","key":"812_CR42","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1080\/03007995.2021.1971179","volume":"37","author":"K Hirata","year":"2021","unstructured":"Hirata K, Ueda K, Komori M, Zagar AJ, Selzler KJ, Nelson AM, et al. Comprehensive population-based survey of migraine in Japan: results of the observational survey of the epidemiology, treatment, and care of migraine (OVERCOME [Japan]) study. Curr Med Res Opin. 2021;37(11):1945\u201355.","journal-title":"Curr Med Res Opin"},{"key":"812_CR43","doi-asserted-by":"publisher","DOI":"10.1177\/17562864251338675","volume":"18","author":"M Waliszewska-Pros\u00f3\u0142","year":"2025","unstructured":"Waliszewska-Pros\u00f3\u0142 M, Straburzy\u0144ski M, Budrewicz S, Marschollek K, Nowaczewska M, Ga\u0107 P, et al. Consulting, diagnosis and treatment patterns in migraine: results from the Migraine in Poland cross-sectional survey. Ther Adv Neurol Disord. 2025;18: 17562864251338675.","journal-title":"Ther Adv Neurol Disord"},{"issue":"2","key":"812_CR44","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/head.14259","volume":"62","author":"RB Lipton","year":"2022","unstructured":"Lipton RB, Nicholson RA, Reed ML, Araujo AB, Jaffe DH, Faries DE, et al. Diagnosis, consultation, treatment, and impact of migraine in the US: results of the OVERCOME (US) study. Headache. 2022;62(2):122\u201340.","journal-title":"Headache"}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-025-00812-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-025-00812-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-025-00812-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:22:19Z","timestamp":1758367339000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-025-00812-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,19]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["812"],"URL":"https:\/\/doi.org\/10.1007\/s40120-025-00812-z","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"type":"print","value":"2193-8253"},{"type":"electronic","value":"2193-6536"}],"subject":[],"published":{"date-parts":[[2025,8,19]]},"assertion":[{"value":"28 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ryotaro Ishii has served as a consultant for Amgen K.K., Eli Lilly Japan K.K., Daiichi Sankyo Co., Ltd., Pfizer Japan Inc., and Otsuka Pharmaceutical Co., Ltd. He has received speaker honoraria from Amgen K.K., Daiichi Sankyo Co., Ltd., and Otsuka Pharmaceutical Co., Ltd. Takahiro Kitano, Masahiro Iijima, Mitsuhiro Nagano, Reiko Yoshikawa, and Kanae Togo are employees of Pfizer Japan Inc. Masahiro Iijima and Kanae Togo are shareholders of Pfizer Inc. James Jackson, Sophie Barlow, Emily Green, William Whitton, and Lucy Hancock are employees of Adelphi Real World.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Data collection was undertaken in line with European Pharmaceutical Marketing Research Association guidelines and as such did not require ethics committee approval. The survey materials were submitted to the PEARL Institutional Review Board (Ref #22-ADRW-143) and deemed to be exempt. In addition, each survey was performed in full accordance with relevant legislation at the time of data collection, including the Helsinki Declaration of 1964 and its later amendments. Using a checkbox, patients provided informed consent to take part in the survey and for the use of their data in scientific publications. No identifiable protected health information was extracted during the survey. Data were collected in such a way that patients and physicians could not be identified directly, with data aggregated before being shared with the subscriber and\/ or for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics\/Ethical Approval"}}]}}